Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.
about
Advances in Medications and Tailoring Treatment for Alcohol Use DisorderImproving clinical outcomes for naltrexone as a management of problem alcohol useA review of pharmacogenetic studies of substance-related disordersPharmacogenetics of OPRM1.The pharmacogenetics of alcohol use disorderAssociations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers.Blocking opioids attenuates physical warmth-induced feelings of social connectionVariation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.Genetic and Environmental Predictors of Alcohol Use in Asian American Young AdultsInteracting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.Naltrexone: Not Just for Opioids AnymoreOpioids and social bonding: naltrexone reduces feelings of social connectionDelta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder.Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.Pharmacogenetically driven treatments for alcoholism: are we there yet?Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review.Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversityEffects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.Experimental psychopathology paradigms for alcohol use disorders: Applications for translational researchA gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology.Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic reviewPharmacogenetics of alcoholism: a clinical neuroscience perspective.Naltrexone metabolism and concomitant drug concentrations in chronic pain patients.Functional significance of subjective response to alcohol across levels of alcohol exposure.Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.Heritability of usual alcohol intoxication and hangover in male twins: the NAS-NRC Twin Registry.
P2860
Q26799814-8A64D7C2-BF9D-415C-BD9A-41CD39E0FD51Q27021406-B0457D1B-60C0-483C-ACC5-2D1BEF318B54Q27312296-4639FC8A-7AEA-4D5B-B5B0-7619C1915C0DQ33568294-46D1F49F-1A21-4A8D-832C-B65E3FCD3BD3Q34463974-79884E0D-5D86-47FF-A5F4-2DFFA8E6D8BBQ34989821-D3311830-C81F-453D-BF7A-8EEB5386F9B5Q35815792-38014772-D33D-4E5E-B5E3-7B99C9EBB428Q35893534-79BD2A07-D479-493A-9074-DCDDE8BEC440Q36322822-F3D9058F-C3DF-40A8-9AD2-AD0EDAB44FF4Q36467926-FF3E84FF-2607-448E-95D7-616A9445ED78Q36540015-F1C3A436-CE01-43E2-8906-9ECD5DEA3182Q36660846-3B3CFDEA-F441-4277-8807-600E7B002AFAQ36843509-5B8D17F8-DB11-4C05-B974-AB3EB2992375Q36931792-9C60F0B2-2439-4989-9C87-0897A5C00081Q37088573-55392369-801C-4B7E-B8E2-263DF0036E6CQ37089324-26EC93A5-AF7F-4442-BB81-B9F5CF5D4CA7Q38010250-EF020C2E-B701-4612-8651-2307F5AC3E74Q38036386-A795E768-85D9-4A38-954C-FADF902B85B4Q38270731-948750F3-863D-4DCF-98DE-138285F9A6CAQ38464015-B947E06F-1B28-4524-A8AF-B37E055A1331Q38718932-C585D7DF-2C34-4DC9-944D-C443CE530D5FQ38764459-D9633182-5C83-4088-B92F-B4D2CC671B0CQ38842262-89D69760-B9E0-4E50-B6A5-79653F86B813Q38856407-FF25D49C-904E-4213-8700-95AAEA6F6A09Q41271163-E10B089C-0B3C-4661-A328-1D0ACB73B7DBQ41664978-44DF3B0C-85A3-4E05-AC98-9F8BDB4AC096Q42157163-531E93B7-511A-4C56-93E4-300B04CF73E3Q46346543-F58F7E2B-D2D1-44D4-9ACE-BE9B07800050Q46484038-E19CAE08-AEFE-4891-99FD-B70B12A02D9FQ47674472-2B07DCE7-EB1A-4230-9B02-ABAC108BAF28Q51050231-EDB5DDB6-9FE5-4B94-A09A-6B3DA4729CDE
P2860
Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pharmacogenetics of naltrexone ...... o-controlled laboratory study.
@ast
Pharmacogenetics of naltrexone ...... o-controlled laboratory study.
@en
type
label
Pharmacogenetics of naltrexone ...... o-controlled laboratory study.
@ast
Pharmacogenetics of naltrexone ...... o-controlled laboratory study.
@en
prefLabel
Pharmacogenetics of naltrexone ...... o-controlled laboratory study.
@ast
Pharmacogenetics of naltrexone ...... o-controlled laboratory study.
@en
P2093
P2860
P356
P1476
Pharmacogenetics of naltrexone ...... o-controlled laboratory study.
@en
P2093
Karen Miotto
Lara A Ray
Pauline F Chin
Spencer Bujarski
P2860
P2888
P304
P356
10.1038/NPP.2011.192
P407
P577
2011-09-07T00:00:00Z
P5875
P6179
1000578926